Comparative analysis of immunophenotypic abnormalities in cellular immunity of uremic patients undergoing either hemodialysis or continuous ambulatory peritoneal dialysis

Renal Failure

Volumn 27, Issue 3, 2005, Pages 279-282

  Griveas, Ioannis ^a   Visvardis, George ^a   Fleva, Aleka ^a   Papadopoulou, Dorothea ^a   Mitsopoulos, Eftathios ^a   Kyriklidou, Parthena ^a   Manou, Eleni ^a   Ginikopoulou, Evdoxia ^a   Meimaridou, Daphni ^a   Paulitou, Aikaterini ^a   Sakellariou, George ^a  

^a PAPAGEORGIOU GENERAL HOSPITAL   (Greece)

Author keywords

Cellular immunity; Continuous ambulatory peritoneal dialysis; Flow cytometry; Hemodialysis; Lymphocyte subsets counts

Indexed keywords

CD16 ANTIGEN; CD19 ANTIGEN; CD2 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD56 ANTIGEN; CD8 ANTIGEN;

ADULT; AGED; ARTICLE; CELLULAR IMMUNODEFICIENCY; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; FEMALE; FLOW CYTOMETRY; HELPER CELL; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; IMMUNOPHENOTYPING; LYMPHOCYTE COUNT; LYMPHOCYTOPENIA; MALE; NATURAL KILLER CELL; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION; UREMIA;

ADULT; AGED; ANTIBODIES, MONOCLONAL; B-LYMPHOCYTES; FEMALE; FLOW CYTOMETRY; FOLLOW-UP STUDIES; HEMODIAFILTRATION; HUMANS; IMMUNITY, CELLULAR; IMMUNOPHENOTYPING; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY; T-LYMPHOCYTE SUBSETS; TREATMENT OUTCOME; UREMIA;

EID: 20044378892     PISSN: 0886022X     EISSN: None     Source Type: Journal    
DOI: 10.1081/JDI-200056620     Document Type: Article

References (25)

1. Sakellariou, G. Immunologic abnormalities in uremia. Hell. Nephrol. 1999, 11 (1), 232-238.
2. Davies, S.J.; Suassuna, J.; Ogg, C.S.; Cameron, J.S. Activation of immunocompetent cells in the peritoneum of patients treated with CAPD. Kidney Int. 1988, 36, 661-668.
3. Casciani, C.V.; DeSimone, C.; Bonini, S. Immunological aspects of chronic uremia. Kidney Int. 1978, 13 (Suppl. 8), 49-54.
4. Qvadracci, L.; Ringden, O.; Krzymanski, M. The effect of uremia and transplantation on lymphocyte subpopulations. Kidney Int. 1976, 10, 179-184.
5. Kamata, K.; Okubo, M.; Sada, M. Immunosuppressive factors in uremic sera are composed of both dialyzable and non-dialyzable components. Clin. Exp. Immunol. 1983, 54, 227-281.
6. Nakhlva, L.S.; Goggin, M.J. Lymphocyte transformation in chronic renal failure. Immunology 1973, 24, 229-235.
7. Shapiro, H.M. Practical Flow Cytometry, 3rd Ed.; Wiley-Liss: New York, 1995; 1-517.
8. Haynes, B.F.; Fauci, A.S. Disorders of the immune system. In Harrison's Principles of Internal Medicine, 15th Ed.; Braunwald, E, et al, Eds.; McGraw-Hill: New York, 2001; 1805-1830.
9. Germenis, A. Functional structure of immune system. In Immunology; Germenis, A, Ed.; Publications Papazisi AEVE: Athens, 2000; 13-35.
10. Germenis, A. Laboratory immunologic methodology. In Immunology; Germenis, A, Ed.; Publications Papazisi AEVE: Athens, 2000; 407-412.
11. Chatenoud, L.; Herbelin, A.; Beaurain, G.; Descamps-Latscha, B. Immune deficiency of the uremic patients. Adv. Nephrol. 1990, 19, 259-274.
12. Haag-Weber, M.; Horl, W.H. The immune system in uremia and during its treatment. New Horizons 1995, 3, 669-679.
13. Descamps-Latscha, B.; Chatenoud, L. T cells and B cells in chronic renal failure. Semin. Nephrol. 1995, 16, 183-191.
14. Giacchino, F.; Pozzato, M.; Formica, M.; Piccoli, G. Improved cell-mediated immunity in CAPD patients as compared to those on hemodialysis. Peritoneal. Dial. Bull. 1984, 4, 209-212.
15. Gogos, X.; Zoupos, N.; Diamantopoulos, A. In vivo improvement of cellular immunity with hemodialysis. In Proc of Hellenic Nephrology Congress. Greek Nephrology Society, 1988.
16. Coen, G.; Haag-Weber, M.; Horl, W.H. Immune dysfunction in uremia. Kidney Int. 1997, 52, 79-82.
17. Carvounis, C.P.; Manis, T.; Coritsidis, G.; Dubinsky, M.; Serpente, P. Total lymphocyte count: a promising prognostic index of mortality in patients on CAPD. Pert. Dial. Int. 2000, 20, 33-38.
18. Mota, E.; Orfao, A.; Mota, M.; Rosca, D.; Georgwsau, M. Lymphocyte Subpopulations and Urinary Infection in the Patients with Diabetic Nephropathy Treated by CAPD, Proceedings of the XXXVII Congress of the European Renal Association-European Dialysis and Transplantation Association, Nice, France, September 17-20, 2000, (Abstract).
19. Alexiewicz, J.M.; Klinger, M.; Pitts, T.O.; Gaciong, Z.; Linker-Israeli, M.; Massry, S.G. Parathyroid hormone inhibits B cell proliferation: implications in chronic renal failure. J. Am. Soc. Nephrol. 1990, 7, 236-244.
20. Whiteside, T.L.; Herberman, R.B. The role of natural killer cells in human disease. Clin. Immunol. Immunopathol. 1989, 53, 1-23.
21. Saoinji, K.; Ohsaka, A. Expansion of CD4+CD16+ blood monocytes in patients with chronic renal failure undergoing dialysis: possible involvement of macrophage colony-stimulating factor. Acta Hematol. 2001, 105, 21-26.
22. Saoinji, K.; Hamada, T.; Higurashi, H.; et al. Plasma macrophage colony-stimulating factor, granulocyte macrophage colony-stimulating factor, and granulocyte colony-stimulating factor levels in CAPD patients. Rinsho Byori 1997, 45, 493-497.
23. Hayakama, M.; Hatano, T.; Sunabe, T.; Higa, T.; Osaua, A. Cytocine production and cytoxicity of lymphocytes in patients on maintenance short or long-term hemodialysis. Nephrol. Dial. Transplant. 1994, 9, 655-661.
24. Wiener, D.; Shah, S.; Malone; Lowell, N.; Lowitt, S.; Rowlands, D.T., Jr. Multiparametric analysis of peripheral blood in the normal pediatric population by flow cytometry. J. Clin. Lab. Anal. 1990, 4, 175-179.
25. Santagostino, A.; Garbaccio, G.; Pistorio, A.; Bolis, V.; Camisasca, G.; Pagliano, P.; Girotto, M. An Italian national multicenter study for the definition of a reference ranges for normal values of peripheral blood lymphocyte subsets in healthy adults. Hematologica 1999, 84, 499-504.